中
|
EN
HOME
ABOUT US
Company profile
Memorabilia
Management team
Shareholder
Contact us
YB1 LEARNING ZONE
YB1 Papers
YB1 Headlines
YB1 Media
R&D AND PRODUCTS
Core technology
Products
Highlights
Patents
NEWS
Company news
Information
YB1 Papers
YB1 Headlines
YB1 Media
YB1 oncolytic bacteria expands the ranks of innovative anti-tumor drugs
2022-03-03 10:47
View details
Innovative therapies promote the rapid development of cancer treatment, and YB1 oncolytic bacteria lead the industry segment
2022-02-25 15:01
View details
Bioinformatics methods and application of biomarkers in precision medicine
2021-12-24 10:45
View details
Recombinant attenuated Salmonella Typhimurium as vaccine vectors to treat cancers
2021-12-23 10:45
View details
Research progress on non-pharmacological intervention of stroke-related sleep disorders
2021-12-22 14:05
View details
Can you produce antibodies after having cancer?
2021-12-21 10:48
View details
The status quo and trend of the development of bacteria in the treatment of tumors
2021-12-20 15:28
View details
Hong Kong scientists create DNA-modified salmonella bacteria for treating cancer
2016-04-26 02:10
View details
